Those changes are considered instrumental steps in promoting the reversal of the epithelial–mesenchymal transition [42], while modulation of vinculin, ROCK1, and uPA will finally antagonize the invasive/migratory proneness of breast cancer cells. The gene discussed is PLAU; the disease is breast cancer.